Zinc(II) niflumato complex effects on MMP activity and gene expression in human endometrial cell lines

Sci Rep. 2021 Sep 27;11(1):19086. doi: 10.1038/s41598-021-98512-9.

Abstract

Endometriosis is a chronic inflammatory disease which increasingly affects young women under 35 years of age and leads to subfertility even infertility. Analysis of the cytotoxic effect of zinc(II) niflumato complex with neocuproine ([Zn(neo)(nif)2] or Zn-Nif) on immortalized human endometriotic cell line (12Z) and on control immortalized human endometrial stromal cell line (hTERT) was performed using xCELLigence technology for approximately 72 h following the treatment with Zn-Nif as well as cell viability Trypan Blue Assay. 12Z cell line proliferated more slowly compared to unaffected cells, whereas hTERT cells did not show similar behavior after treatment. The complex probably reduces the effect of pro-inflammatory pathways due to the effect of NSAID, while presence of zinc might reduce the level of ROS and regulate ER2 levels and MMP activity. The observed effects and high selectivity for rapidly proliferating cells with increased inflammatory activity suggest a good prognosis of successful decrease of endometriosis stage with this complex.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cell Survival / drug effects
  • Drug Evaluation, Preclinical
  • Endometriosis / drug therapy*
  • Endometriosis / pathology
  • Endometrium / cytology
  • Endometrium / pathology
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation / drug effects
  • Humans
  • Matrix Metalloproteinases / metabolism*
  • Organometallic Compounds / pharmacology*
  • Organometallic Compounds / therapeutic use
  • Phenanthrolines / pharmacology*
  • Phenanthrolines / therapeutic use
  • Zinc / pharmacology*
  • Zinc / therapeutic use

Substances

  • Organometallic Compounds
  • Phenanthrolines
  • neocuproine
  • Matrix Metalloproteinases
  • Zinc